HomeMARKET REPORTS

MARKET REPORTS

Global Wilms Tumor Treatment Market Research Report 2023: Rise in Chemotherapy Regimens, Rising Incidence of Wilms Tumor, and Advancements in Surgical Techniques Bolsters Growth...

Global Wilms Tumor Treatment Market has valued at USD 1.24 billion in 2022 and is anticipated to project robust growth in the forecast period with a CAGR of 4.40% through 2028

Dermatology Lasers Market to grow by USD 729.65 million from 2023-2028, North America to account for 39% of market growth – Technavio

The dermatology lasers market size is expected to grow by USD 729.65 million from 2023 to 2028. In addition, the momentum of the market will progress at a CAGR of 7.4% during the forecast period, according to Technavio Research. The market is categorized by End-user (Dermatology clinics, Hospitals, and Others), Product (Solid-state dermatology lasers, Gas dermatology lasers, and Pulsed dye dermatology lasers), and Geography (North America, Europe, Asia, and Rest of World (ROW)).

$3.34 Billion DNA Data Storage (Cloud, On-Premises) Markets, 2030: Focus on Sequence-based DNA Data Storage, Structure-based DNA Data Storage

The DNA Data storage market is projected to grow from USD 76 million in 2024 and is expected to reach USD 3,348 million by 2030, growing at a CAGR of 87.7% from 2024 to 2030.

Lyophilization Equipment and Services Market to grow by USD 2.65 billion from 2023 to 2028, North America to account for 36% of market growth...

The market is segmented by end-user (pharmaceutical and biotechnology companies and other healthcare service providers), product (tray-style freeze dryer, manifold freeze dryer, and rotary freeze dryer), and geography (North America, Europe, Asia, and Rest of World (ROW)).

Ustekinumab (Stelara) by Janssen Biotech Biosimilars Pipeline Review 2023 | Information on Approved Drugs and Drug Candidates in Research and Development as Biosimilar Antibodies

Developed by Janssen Biotech, the blockbuster therapeutic antibody STELARA (INN: ustekinumab) is an approved human interleukin-12 and interleukin-23 antagonist indicated for the treatment of moderate to severe plaque psoriasis in adults and pediatric patients (6 years or older) who are candidates for phototherapy or systemic therapy, active psoriatic arthritis in adults, as well as for adult patients with moderately to severely active Crohn's disease and moderately to severely active ulcerative colitis. Stelara was approved in the US and EU in 2009. The Stelara patent expires September 2023 in the United States.

Global Colonoscopy Devices Business Research Report 2023-2030 | Market to Reach $2.2 Billion with Visualization Systems Accounting for $1.1 Billion

The global market for Colonoscopy Devices estimated at US$1.6 Billion in the year 2022, is projected to reach a revised size of US$2.2 Billion by 2030, growing at a CAGR of 4.2% over the analysis period 2022-2030.

ICU Beds Global Market Report 2024

The "ICU Beds Global Market Report 2024" has been added to ResearchAndMarkets.com's offering. The ICU beds market is set to grow from $2.02 billion in...

Cardiac Bio Implant Devices Market Report 2023-2030

The "Cardiac Bio Implant Devices Market, Size, Global Forecast 2023-2030, Industry Trends, Growth, Share, Outlook, Impact of Inflation, Opportunity Company Analysis" report has been added to ResearchAndMarkets.com's offering

Filter Needles Market Size, Share & Trends Report 2023-2030: Global Analysis by Raw Material (Stainless Steel, Glass), and End-use (Hospital, Clinics, Ambulatory Surgery Centers)...

The "Filter Needles Market Size, Share & Trends Analysis Report By Raw Material (Stainless Steel, Glass, Others), By End-use (Hospital, Clinics, Ambulatory Surgery Centers,...